The downturn highlighted the dilemma for policymakers who embarked on aggressive rate hikes in a battle to keep inflation at bay, and yet also need to try and forestall potential recessions
The Danish drugmaker s share price has more than doubled in the two years since the drug debuted, turning Novo into Europe s second-most-valuable listed company after Louis Vuitton.
The carmaker said it will aim to improve its cash flow in the second half as it hikes prices and cuts costs, even after it lowered its 2023 outlook for deliveries.